Live & On-Demand Webinars

Protective and Pathologic Skin Type 2 Immune Responses Against Microbes

Join us to explore how the skin’s immune system walks a fine line between protection and pathology. As a crucial barrier, the skin hosts a diverse microbiome that supports immune development. But when this delicate ecosystem is disrupted, it can trigger harmful immune responses.

In this session, Dr. Philipp Starkl, will share new insights into the mechanisms of type 2 immunity during bacterial skin infections, and reveal how protective responses can shift into maladaptive allergic reactions. Don’t miss this opportunity to gain a deeper understanding of skin immunology and its impact on allergy development.

Discover Polymer Prodrug Nanocarriers: A Breakthrough in Cancer Therapy

Join us to explore how advanced polymer-drug conjugates are transforming cancer treatment through a novel “drug-initiated” approach. This innovative method enables the controlled growth of vinyl polymers from anticancer drug-bearing initiators, resulting in well-defined nanocarriers with high drug loading and precise, spatio-temporal release. Our experts will reveal how this versatile technique is tailored for different drugs, polymers, and linkers to optimize anticancer activity both in vitro and in vivo. The session will also highlight cutting-edge applications in imaging, combination therapy, and safer subcutaneous drug administration that overcome the limitations of traditional IV chemotherapy. Don’t miss this opportunity to gain insights into groundbreaking research that is reshaping oncology!

Discover the NLRP1 Inflammasome’s Role in Epithelial Immunity

Join us to explore how the NLRP1 inflammasome acts as a critical immune sensor in epithelial tissues, safeguarding the body against environmental and infectious threats. Dr. Etienne Meunier will present his team’s latest findings on the ribotoxic stress response and its role in activating the NLRP1 inflammasome. His cutting-edge research uncovers the molecular mechanisms that protect epithelial barriers, shedding light on human-specific immune defense systems.
This webinar offers valuable insights into the intricate pathways that regulate innate immunity, providing a foundation for advancements in therapeutic strategies for immune-related diseases and conditions. Don’t miss this opportunity to learn from a leading expert in the field!

Discover how biostabilized human skin models provide critical insights into the immune system’s response to the mRNA-1273 COVID-19 vaccine. Dr. Manon Scholaert explores how immune cells react and communicate within human skin following vaccine administration. Her research sheds light on the molecular events that drive immune responses and intercellular communication, using cutting-edge bioengineering techniques to preserve and study human skin ex vivo. This approach offers valuable insights for the development of more effective vaccines and therapeutics.

Explore the complex world of mast cells (MCs), pivotal in both defending against environmental threats and driving chronic inflammatory diseases, impacting countless individuals worldwide. Prof. Marcus Maurer delves into the latest research on MCs, particularly in skin health, their dual roles in conditions like urticaria and mastocytosis, and the innovative methodologies for their study. Uncover cutting-edge therapeutic approaches being developed to mitigate MC-driven inflammation, including mediator inhibition and cell depletion, promising a new horizon in treatment strategies.

Discover the rising challenge of allergies, now affecting over 220 million globally, with a focus on allergic asthma and food allergies. Dr. Reber unveils groundbreaking research from a collaboration with NEOVACS, INSERM, and Institut Pasteur, introducing kinoid vaccines. These innovative vaccines target key allergic pathways, offering a cost-effective, long-lasting solution against severe allergic reactions. Dive deep into the science and potential of this promising treatment.

Exposure to everyday toxins and chemicals can disrupt epithelial barriers, leading to chronic inflammation, as revealed in extensive research utilizing innovative methods mimicking human tissues. This research also highlights the discovery of over 20 “rescue molecules” that have potential to mitigate these damaging effects, offering a new avenue towards healing damaged epithelial barriers and disease prevention.

The field of vaccination is currently at a turning point with new ideas and innovations, relying on basic research to understand and translate human immunity. The development of alternative routes of immunization for increased efficacy, such as intradermal and transcutaneous techniques, is becoming more popular due to advances in knowledge about the plasticity of antigen-presenting cells and the recruitment of inflammatory cells.